Femasys FEMY
NASDAQ FEMY
$2.96 +0.23 (+8.42%)
At close: Aug 21, 2026 · 4:00 PM EDT

Femasys (FEMY) Other Non Operating Income (2020 - 2025)

Femasys' (FEMY) quarterly Other Non Operating Income came in at -$260000.0 in Q2 2025, down 131.65% on a QoQ basis from $821515.0 in Q2 2021.

Femasys (FEMY) Other Non Operating Income (2020 - 2025) Analysis & Trends

Femasys (FEMY) has 3 years of Other Non Operating Income data on file, last reported at -$260000.0 in Q2 2025.

  • Quarterly Other Non Operating Income changed N/A year-over-year to -$260000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$260000.0 (changed N/A YoY) and the FY2025 annual result came in at $415511.0, changed N/A from the prior year.
  • Other Non Operating Income eased to -$260000.0 in Q2 2025, from $821515.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $821515.0 in Q2 2021 to a low of -$260000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Femasys 9.97 Mn 8.53 Mn 189,391.00

Historic Data

Download Data
DateValue
Jun 30, 2025 -260,000.00
Jun 30, 2021 821,515.00
Dec 31, 2020 10,000.00